Establishment of Normal Ranges for Newly Developed Cardiovascular Assays


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 718-05
    Sponsor Protocol Number: 718-05

About this study

This study is being done to establish normal ranges of proteins that are normally present in the blood and urine so as to compare those values to the ones obtained from patients with heart disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Healthy adults (45-85 years old) with no known diseases and using no medications that interfere with the natriuretic peptide systems we are studying.

Exclusion Criteria:   

  • Younger than 45 years old and taking prescription drugs.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Burnett, M.D.

Closed for enrollment

Contact information:

Lynn Harstad


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer